Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia: Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Naftopidil for the Treatment of Lower Urinary Tract Symptoms Compatible With Benign Prostatic Hyperplasia: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433799/all/Vaccines_for_preventing_Japanese_encephalitis_Unchanged. Accessed 29 March 2024.
Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433799/all/Vaccines_for_preventing_Japanese_encephalitis_Unchanged. Accessed March 29, 2024.
Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia: Cochrane systematic review. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/433799/all/Vaccines_for_preventing_Japanese_encephalitis_Unchanged
Naftopidil for the Treatment of Lower Urinary Tract Symptoms Compatible With Benign Prostatic Hyperplasia: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2024 March 29]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433799/all/Vaccines_for_preventing_Japanese_encephalitis_Unchanged.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia: Cochrane systematic review
ID - 433799
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433799/all/Vaccines_for_preventing_Japanese_encephalitis_Unchanged
DB - Evidence Central
DP - Unbound Medicine
ER -